Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2009 October;144(5) > Giornale Italiano di Dermatologia e Venereologia 2009 October;144(5):603-12

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

REVIEWS   

Giornale Italiano di Dermatologia e Venereologia 2009 October;144(5):603-12

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: English

Sweet’s syndrome: an update and review

Yi S. 1, Bhate C. 1, Schwartz R. A. 1, 2

1 Department of Dermatology, New Jersey Medical School, Newark, NJ, USA 2 Department of Pathology, New Jersey Medical School, Newark, NJ, USA


PDF


Sweet’s syndrome, or acute neutrophilic dermatosis, is an unusual dermatologic disorder that may serve as a marker of leukemia or lymphoma, other malignancy or another serious systemic disorder. It is characterized by the sudden eruption of tender discrete erythematous nodules or plaques which are sometimes associated with fever, neutrophilic leukocytosis, and a dense dermal infiltrate of mature neutrophils. It may occur as a hypersensitivity reaction with cytokines playing a pivotal role. It may remit after the treatment of an underlying cancer or discontinuation of an offending pharmacologic agent, although it con also resolve spontaneously without therapeutic intervention. The gold standard of treatment is with systemic corticosteroids; however, potassium iodide, colchicine and other therapeutic agents have been utilized successfully.

top of page